Positive Emotions After Acute Coronary Events at Northwestern University (PEACE-NU)

November 28, 2022 updated by: Judith Moskowitz, Northwestern University

Positive Psychology for Acute Coronary Syndrome Patients: A proof-of Concept Feasibility Trial

This study is a single-arm, 12-week trial to test the feasibility of a PP-MI intervention for patients recently admitted following ACS. PP-MI is a novel positive psychology-based health behavior intervention that is adapted for patients hospitalized for ACS. The intervention aims to cultivate positive emotions in this vulnerable population that could provide broad and significant health benefits, and may have distinct-and more powerful-effects than simply attempting to dampen negative emotions.

The primary aim is to assess whether the intervention exercises are feasible and linked with immediate boosts in positive affect upon completion. The secondary goal is to provide the research team with greater experience recruiting inpatients with an ACS, successfully completing intervention sessions, and administering psychological and medical assessments by phone.

Study Overview

Detailed Description

The initial study visit will occur in-person two weeks after discharge from the hospital. Participants will meet with a member of the study staff (the study "trainer") and complete self-report questionnaires assessing health behavior adherence and mental and physical health. Then, a study interventionist will provide a treatment manual for the positive psychology + motivational interviewing intervention, review the rationale for the initial exercise, and assign the first exercise. If the participant is in the positive psychology + motivational interviewing condition, the trainer will explain the rationale for both the positive psychology and goal-setting and motivational interviewing portions of the program, and will be assigned the first exercise. Participants will then be given an accelerometer, which they will be asked to wear for 7 days to ensure that they are comfortable with the device and that useable data can be obtained from the participant. Participants will then complete twelve 30-minute weekly phone sessions with a study trainer. The phone sessions primarily will include a review of the prior week's session content and a discussion of the rationale and assignment of the next week's exercise/assignment. Upon the completion of these calls, a blinded member of the study staff will call participants to administer self-report outcome measures. Participants will also be asked to wear an accelerometer at the follow-up timepoint as an objective measure of physical activity, which they will return by mail to the study staff.

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Northwestern University Feinberg School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Eligible patients must meet at least two of three World Health Organization criteria for an acute MI: typical chest pain, elevated cardiac enzymes, and electrocardiographic changes consistent with MI. For UA, participants must have new-onset angina within 2 months, exacerbation of previous angina with rest or with minimal exercise, or angina within 2 weeks of MI.
  • Suboptimal adherence to health behaviors: eligible patients must meet a total item score of <15 (suboptimal) based on three Medical Outcomes Study-Specific Adherence Scale (MOS SAS) items OR a total item score of 15 and a physical activity item score of <5.

Exclusion Criteria:

  • Cognitive deficits, assessed via a 6-item cognitive screen,33 used to assess appropriate participation of medically ill patients in research studies and defined by a score of < 4.
  • Medical conditions precluding interviews or likely to lead to death within 6 months, determined in consultation with the primary treatment team and Dr. James Flaherty.
  • Individuals who have undergone coronary artery bypass surgery, or any open heart surgery, in the past 1 year.
  • Inability to perform moderate to vigorous physical activity, as defined by an inability to walk without aid of an assistive device such as a walker or cane, OR inability to walk at a steady pace for at least 5 minutes without stopping.
  • Inability to communicate in English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Positive Psychology + Motivational Interviewing
Participants will complete weekly positive psychology exercises and will systematically set goals related to physical activity. Study trainers will review the positive psychology exercises on the phone each week and will use motivational interviewing techniques to facilitate goal setting.
For the positive psychology portion of the intervention, the study trainer will (a) review the week's positive psychology exercise, (b) discuss the rationale of the next week's positive psychology exercise through a guided review of the positive psychology manual, and (c) assign the next week's positive psychology exercise. For the motivational interviewing portion, participants will (a) review their physical activity goal from the prior week, (b) discuss techniques for improving physical activity, and (c) set a physical activity goal for the next week. Study trainers will use motivational interviewing techniques to facilitate goal setting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of intervention sessions completed by participants
Time Frame: 12 weeks
Measured by number of intervention sessions completed by participants
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in physical activity
Time Frame: Baseline, 12 week
As measured by accelerometer
Baseline, 12 week
Change in medication adherence
Time Frame: Baseline, 12 week
Measured by SRMA, a two-item self-report medication adherence scale measuring percentage of time patients report taking their heart medications in the past one and two weeks.
Baseline, 12 week
Change in dietary adherence
Time Frame: Baseline, 12 week
Measured by the MEDFICTS scale, a National Cholesterol Education Program-developed scale inquiring about saturated fat.
Baseline, 12 week
Change in positive affect
Time Frame: Baseline, 12 week
Measured by the Positive and Negative Affect Schedule (PANAS)
Baseline, 12 week
Change in trait optimism
Time Frame: Baseline, 12 week
Measured by the Life Orientation Test-Revised (LOT-R)
Baseline, 12 week
Change in state optimism
Time Frame: Baseline, 12 week
Measured by the State Optimism Scale developed by Dr. Jeff Huffman
Baseline, 12 week
Change in anxiety
Time Frame: Baseline, 12 week
Measured by the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A)
Baseline, 12 week
Change in depression
Time Frame: Baseline, 12 week
Measured by the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D)
Baseline, 12 week
Change in physical function
Time Frame: Baseline, 12 week
Measured by the Duke Activity Status Index (DASI)
Baseline, 12 week
Change in health-related quality of life
Time Frame: Baseline, 12 week
Measured by the Short Form 12 (SF-12)
Baseline, 12 week
Change in adherence to health behaviors
Time Frame: Baseline, 12 week
Measured by the three items from the Medical Outcomes Study-Specific Adherence Scale (MOS SAS)
Baseline, 12 week
Change in cardiac symptoms
Time Frame: Baseline, 12 week
Measured by a checklist taken from the Women and Ischemia Syndrome Evaluation Study
Baseline, 12 week
Change in physical activity
Time Frame: Baseline, 12 week
Measured by the self-report International Physical Activity Questionnaire (IPAQ)
Baseline, 12 week
Change in perceived stress
Time Frame: Baseline, 12 week
Measured by the perceived stress scale (PSS-4) measure
Baseline, 12 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Judith Moskowitz, PhD, MPH, Northwestern University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 24, 2020

Primary Completion (ACTUAL)

March 13, 2020

Study Completion (ACTUAL)

March 13, 2020

Study Registration Dates

First Submitted

October 26, 2018

First Submitted That Met QC Criteria

August 19, 2019

First Posted (ACTUAL)

August 20, 2019

Study Record Updates

Last Update Posted (ACTUAL)

December 1, 2022

Last Update Submitted That Met QC Criteria

November 28, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ACS - Acute Coronary Syndrome

Clinical Trials on Positive Psychology + Motivational Interviewing

3
Subscribe